Z-0590-2021 Class II Terminated
FDA device recall Z-0590-2021 was initiated by Enterix, Inc. on Oct 8, 2020 and is designated Class II. Reason for recall: Product does not meet internal testing criterion; use of the product may result in a potential false positive test result and may lead to patients undergoing unnecessary follow-up diagnostic… The recall status is terminated (terminated Jan 10, 2023). Affected quantity: US: 5,256 vials (131,400 test strips); OUS:1051 vials.
Recall details
- Product Type
- Devices
- Report Date
- Dec 23, 2020
- Initiation Date
- Oct 8, 2020
- Termination Date
- Jan 10, 2023
- Voluntary/Mandated
- Voluntary: Firm initiated
- Product Quantity
- US: 5,256 vials (131,400 test strips); OUS:1051 vials
Product description
InSure ONE Test Strips (25 pack) vials-fecal immunochemical test (FIT) qualitatively detects human hemoglobin from blood in fecal samples Model 12045.01.
Reason for recall
Product does not meet internal testing criterion; use of the product may result in a potential false positive test result and may lead to patients undergoing unnecessary follow-up diagnostic procedure, i.e., colonoscopy or sigmoidoscopy
Distribution pattern
Worldwide distribution - US Nationwide and the country of Australia.
Code information
Lot Numbers: 770G11 and 770G21
Source
- Dataset
- openFDA device recall enforcement reports
- FDA record
- This recall in openFDA (JSON)
- Enforcement Report
- Search FDA's Enforcement Report for Z-0590-2021
- openFDA file date
- Nov 10, 2026
- Loaded by RegDataLab
- Nov 11, 2026